EVAXEvaxion Biotech A/S

Nasdaq evaxion-biotech.com


$ 3.53 $ 0.00 (0 %)    

Tuesday, 04-Jun-2024 09:34:15 EDT
QQQ $ 454.82 $ 1.24 (0.27 %)
DIA $ 398.57 $ 1.27 (0.33 %)
SPY $ 530.36 $ 0.59 (0.11 %)
TLT $ 91.26 $ 1.07 (1.17 %)
GLD $ 225.37 $ -1.95 (-0.9 %)
$ 3.52
$ 3.53
$ 0.00 x 0
$ 0.00 x 0
$ 3.53 - $ 3.53
$ 2.82 - $ 18.50
7,898
na
133.4M
$ 1.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

 evaxion-presents-validating-immune-data-from-ongoing-phase-2-trial-with-ai-designed-evx-01-vaccine-at-the-asco-annual-meeting-2024

Evaxion's AI-designed cancer vaccine, EVX-01, triggered a specific and tumor-targeting immune response in all assayed melan...

 evaxion-biotech-q1-eps-003-beats-056-estimate-sales-5100k-beat-3700k-estimate

Evaxion Biotech (NASDAQ:EVAX) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.5...

 evaxion-received-a-letter-from-the-nasdaq-listing-qualifications-department-notifying-that-it-is-not-currently-in-compliance-with-the-minimum-stockholders-equity-requirement

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

 hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

 ladenburg-thalmann-upgrades-evaxion-biotech-to-buy-announces-8-price-target

Ladenburg Thalmann analyst Ahu Demir upgrades Evaxion Biotech (NASDAQ:EVAX) from Neutral to Buy and announces $8 price target.

 evaxion-biotech-q4-eps-016-beats-160-estimate-sales-7300k

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(1.6...

 hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

Core News & Articles

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

 hc-wainwright--co-initiates-coverage-on-evaxion-biotech-with-buy-rating-announces-price-target-of-14

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Evaxion Biotech (NASDAQ:EVAX) with a Buy rating...

 evaxion-regains-compliance-with-nasdaq-minimum-bid-price-requirement

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

 why-ch-robinson-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

 why-amd-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD rep...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION